Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Clark

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Asia-Pacific Journal of Clinical Oncology|June 5, 2025
Identification of Clinical Variation of Interest in Standard of Care Practice in a Statewide Bench Marking Audit of Brain Tumor Patient CareHui K Gan, Laura Tam, Janine Scott, et al.
Pulmonary Pharmacology & Therapeutics|February 25, 2023
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta SyndromeMalcolm Begg, Augustin Amour, Emily Jarvis, et al.
Head & Neck|September 18, 2014
Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the systemArdalan Ebrahimi, Ziv Gil, Moran Amit, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2019
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase <i>δ</i> InhibitorMalcolm Begg, Chris D Edwards, J Nicole Hamblin, et al.
Human Molecular Genetics|May 22, 2025
Improving genetic diagnostic yield in familial and sporadic cerebral cavernous malformations: detection of copy number and deep Intronic variantsNeblina Sikta, Samuel Gooley, Timothy E Green, et al.
Haematologica|May 11, 2019
Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of <i>PIK3CD</i>-encoded phosphoinositide 3-kinase δDavid J Swan, Dominik Aschenbrenner, Christopher A Lamb, et al.
Nature Cell Biology|April 28, 2022
Kinase-independent synthesis of 3-phosphorylated phosphoinositides by a phosphotransferaseGlenn F W Walpole, Jonathan Pacheco, Neha Chauhan, et al.
Respiratory Research|October 19, 2024
CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPDMirco Govoni, Michele Bassi, Luca Girardello, et al.
JCI Insight|October 22, 2016
Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutationsIsabel Huang-Doran, Patsy Tomlinson, Felicity Payne, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 18, 2025
Adjuvant Chemoradiotherapy for Oral Cavity SCC With Minor and Major Extranodal ExtensionMirko Manojlovic-Kolarski, Susie Su, Ilian Weinreb, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Asia-Pacific Journal of Clinical Oncology|June 5, 2025
Identification of Clinical Variation of Interest in Standard of Care Practice in a Statewide Bench Marking Audit of Brain Tumor Patient CareHui K Gan, Laura Tam, Janine Scott, et al.
Pulmonary Pharmacology & Therapeutics|February 25, 2023
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta SyndromeMalcolm Begg, Augustin Amour, Emily Jarvis, et al.
Head & Neck|September 18, 2014
Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the systemArdalan Ebrahimi, Ziv Gil, Moran Amit, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2019
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase <i>δ</i> InhibitorMalcolm Begg, Chris D Edwards, J Nicole Hamblin, et al.
Human Molecular Genetics|May 22, 2025
Improving genetic diagnostic yield in familial and sporadic cerebral cavernous malformations: detection of copy number and deep Intronic variantsNeblina Sikta, Samuel Gooley, Timothy E Green, et al.
Haematologica|May 11, 2019
Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of <i>PIK3CD</i>-encoded phosphoinositide 3-kinase δDavid J Swan, Dominik Aschenbrenner, Christopher A Lamb, et al.
Nature Cell Biology|April 28, 2022
Kinase-independent synthesis of 3-phosphorylated phosphoinositides by a phosphotransferaseGlenn F W Walpole, Jonathan Pacheco, Neha Chauhan, et al.
Respiratory Research|October 19, 2024
CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPDMirco Govoni, Michele Bassi, Luca Girardello, et al.
JCI Insight|October 22, 2016
Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutationsIsabel Huang-Doran, Patsy Tomlinson, Felicity Payne, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 18, 2025
Adjuvant Chemoradiotherapy for Oral Cavity SCC With Minor and Major Extranodal ExtensionMirko Manojlovic-Kolarski, Susie Su, Ilian Weinreb, et al.
Pageof 21